Friday, September 11, 2009 8:11:11 AM
I agree with you that there is "theorically" the potential of further dilution increase 15 times. But the real question you should ask yourself is :
- Do i trust the management to handle the future of the company. I believe you do as much as i do because you like the business plan they have and the way the comapny has been run lately. The company is moving at a very fast pace and on the right track with these management.
- Do you think it would be in the best interest of the management to dilute a lot the stock without any business reason in front of the dilution ? I don't think so, and you shouldn't if you trust the quality of the management
- Do you think that the board of Director would vote in favor of a dilution if it isn't positive for the shareholder? I think the board of director is acting in favor of the shareholder and nothing else therefore they are a solid protection to stupid dilution potential
- To do dilution, it means they would raise money. To raise money they need to get in touch with institutional. Institutional would invest if they believe it would provide them return. To provide them return it needs to be a valuable business plan that explain any given investment. So we could consider that institutional would be a good protection as they wouldn't accept a stupid deal that wouldn't make any financial sense.
All in all if you trust the business plan you should trust that there is enough protection to avoid any given dilution that wouldn't help the company and the shareholder over the long term.
- Do i trust the management to handle the future of the company. I believe you do as much as i do because you like the business plan they have and the way the comapny has been run lately. The company is moving at a very fast pace and on the right track with these management.
- Do you think it would be in the best interest of the management to dilute a lot the stock without any business reason in front of the dilution ? I don't think so, and you shouldn't if you trust the quality of the management
- Do you think that the board of Director would vote in favor of a dilution if it isn't positive for the shareholder? I think the board of director is acting in favor of the shareholder and nothing else therefore they are a solid protection to stupid dilution potential
- To do dilution, it means they would raise money. To raise money they need to get in touch with institutional. Institutional would invest if they believe it would provide them return. To provide them return it needs to be a valuable business plan that explain any given investment. So we could consider that institutional would be a good protection as they wouldn't accept a stupid deal that wouldn't make any financial sense.
All in all if you trust the business plan you should trust that there is enough protection to avoid any given dilution that wouldn't help the company and the shareholder over the long term.
Recent TENX News
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/20/2026 09:05:19 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 10:55:54 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 09:26:02 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 08:31:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 09:08:07 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:56:40 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/12/2026 09:01:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2026 08:06:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 12:00:07 PM
- Tenax Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/12/2026 11:00:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/08/2026 10:19:02 PM
- Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/08/2026 08:05:00 PM
- Tenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial Officer • GlobeNewswire Inc. • 05/04/2026 11:00:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/22/2026 12:19:57 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/22/2026 12:17:37 PM
